ACER insider filings

Acer Therapeutics Inc. — 43 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-11-20. Screen ACER transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ACER between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Acer Therapeutics Inc.

FiledFormInsiderReported transactionsSource
2023-11-204ASELAGE STEVE — DirectorDisposition to issuer (D): 483,741EDGAR
2023-11-204DUNN JOHN MICHAEL — DirectorDisposition to issuer (D): 27,380EDGAR
2023-11-204Joseph Donald — See RemarksDisposition to issuer (D): 14,285EDGAR
2023-11-204Schelling Chris — PRESIDENT AND CEO, Director, 10% ownerDisposition to issuer (D): 2,712,529EDGAR
2023-11-204PALMIN HARRY S — CHIEF FINANCIAL OFFICERDisposition to issuer (D): 125,000EDGAR
2023-11-204Davis Jefferson E — CHIEF BUSINESS OFFICERDisposition to issuer (D): 71,645EDGAR
2023-03-164Quartel Adrian W — Chief Medical OfficerGrant/award (A): 30,000 (derivative) @ $0EDGAR
2023-03-164Paul Bernard H — Chief People OfficerGrant/award (A): 30,000 (derivative) @ $0EDGAR
2023-03-164PALMIN HARRY S — Chief Financial OfficerGrant/award (A): 30,000 (derivative) @ $0EDGAR
2023-03-164Klopp John Michael — Chief Technical OfficerGrant/award (A): 30,000 (derivative) @ $0EDGAR
2023-03-164Joseph Donald — Chief Legal Officer and SecyGrant/award (A): 30,000 (derivative) @ $0EDGAR
2023-03-164Hayden Tanya — Chief Operating OfficerGrant/award (A): 30,000 (derivative) @ $0EDGAR
2023-03-164GRIFFIN MICHELLE RENEE — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-03-164DUNN JOHN MICHAEL — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-03-164Davis Jefferson E — Chief Business OfficerGrant/award (A): 30,000 (derivative) @ $0EDGAR
2023-03-164ASELAGE STEVE — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-03-164Amello Jason — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-12-014Schelling Chris — President & CEO, Director, 10% ownerPurchase (P): 819,672 @ $1.22EDGAR
2022-12-014ASELAGE STEVE — DirectorPurchase (P): 409,836 @ $1.22EDGAR
2022-06-224Hayden Tanya — Chief Operating OfficerGrant/award (A): 25,000 (derivative) @ $0EDGAR
2022-02-234Quartel Adrian W — Chief Medical OfficerGrant/award (A): 200,000 (derivative) @ $0EDGAR
2022-01-214Paul Bernard H — Chief People OfficerGrant/award (A): 25,000 (derivative) @ $0EDGAR
2022-01-194Seibt Matthew — Chief Commercial OfficerGrant/award (A): 25,000 (derivative) @ $0EDGAR
2022-01-194Schelling Chris — President & CEO, Director, 10% ownerGrant/award (A): 50,000 (derivative) @ $0EDGAR
2022-01-194PALMIN HARRY S — Chief Opp. and Financial OffrGrant/award (A): 25,000 (derivative) @ $0EDGAR
2022-01-194Klopp John Michael — Chief Technical OfficerGrant/award (A): 25,000 (derivative) @ $0EDGAR
2022-01-194Joseph Donald — Chief Legal Officer and SecyGrant/award (A): 25,000 (derivative) @ $0EDGAR
2022-01-194GRIFFIN MICHELLE RENEE — DirectorGrant/award (A): 18,500 (derivative) @ $0EDGAR
2022-01-194DUNN JOHN MICHAEL — DirectorGrant/award (A): 18,500 (derivative) @ $0EDGAR
2022-01-194Davis Jefferson E — Chief Business OfficerGrant/award (A): 25,000 (derivative) @ $0EDGAR
2022-01-194ASELAGE STEVE — DirectorGrant/award (A): 18,500 (derivative) @ $0EDGAR
2022-01-194Amello Jason — DirectorGrant/award (A): 18,500 (derivative) @ $0EDGAR
2021-12-134ASELAGE STEVE — DirectorPurchase (P): 2,016 @ $2.15 · Purchase (P): 7,984 @ $2.04EDGAR
2021-02-054Davis Jefferson E — Chief Business OfficerGrant/award (A): 100,000 (derivative) @ $0EDGAR
2021-01-204ASELAGE STEVE — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-01-204Amello Jason — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-01-204Seibt Matthew — Chief Commercial OfficerGrant/award (A): 20,000 (derivative) @ $0EDGAR
2021-01-204Schelling Chris — President & CEO, Director, 10% ownerGrant/award (A): 40,000 (derivative) @ $0EDGAR
2021-01-204PALMIN HARRY S — Chief Opp. and Financial OffrGrant/award (A): 60,000 (derivative) @ $0EDGAR
2021-01-204Klopp John Michael — Chief Technical OfficerGrant/award (A): 20,000 (derivative) @ $0EDGAR
2021-01-204Joseph Donald — Chief Legal Officer and SecyGrant/award (A): 60,000 (derivative) @ $0EDGAR
2021-01-204GRIFFIN MICHELLE RENEE — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-01-204DUNN JOHN MICHAEL — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR

Recent 8-K events — Acer Therapeutics Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-11-208-K2.01 — Completion of Acquisition or Disposition of Assets
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-088-K5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
EDGAR
2023-11-028-K1.01 — Entry into a Material Definitive Agreement
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-08-318-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-08-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-06-268-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-06-078-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2023-05-228-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2023-05-158-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-048-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ACER returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs